Evidence map›Paper›PMID 26424377›Full record

ReviewTropical animal health and production2016

Comparative aspects of immunity and vaccination in human and bovine trichomoniasis: a review.

Aspinas Chapwanya, Abubakar Yusha'u Usman, Pete Charles Irons

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Tropical animal health and production, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aspinas ChapwanyaInstitute of Food, Nutrition and Well-being (IFNuW), University of Pretoria, Pretoria, South Africa. achapwanya@rossvet.edu.kn.
Abubakar Yusha'u UsmanDepartment of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, Pretoria, South Africa.
Pete Charles IronsDepartment of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, Pretoria, South Africa.
University of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichomonas vaginalis and Tritrichomonas foetus are important extracellular protozoans that cause, respectively, human and bovine venereal diseases. Trichomonads are extracellular parasites that primarily inhabit the genital tracts of the mammalian hosts where they overcome the mucus barrier and parasitize mucosa by contact-dependent or contact-independent cytotoxicity. Transient immunity is usually achieved by the host after clinical infection. At present, vaccination in cattle reduces infection rates and reproductive wastage in affected herds. After vaccination, immunoglobulin G (IgG) levels increase in systemic circulation while immunoglobulin A (IgA) levels rise in the vagina. Only moderate protection is conferred by means of vaccination. Future vaccine development strategies are needed for cattle to enhance the antigenic component or use adjuvant that strongly activates the innate immune response to produce safe and potent vaccines. This paper reviews the current knowledge of the immunology of trichomoniasis infection and the challenges and potential of vaccines in the control of the infection in human and bovine trichomoniasis.

Indexed as

VaccinationAnimalsCattleCattle DiseasesHumansProtozoan VaccinesTrichomonas InfectionsProtozoan VaccinesBovineFertilityImmunityTrichomonas vaginalisTritrichomonas foetusVaccinationVenereal infection

Identifiers

PMID26424377
OpenAlexW1853271836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.